Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT07083518
Eligibility Criteria:
Inclusion Criteria:
1. Female breast cancer survivors aged 18-65 years.
2. Initially diagnosed with stage I-III non-metastatic breast cancer.
3. Between 6 months and 5 years after completion of initial curative surgery +/- radiation/chemotherapy.
4. allowed to be on endocrine therapy and/or anti-HER2 targeted therapy.
5. Self-reported cognitive complaints following cancer treatment.
6. Right-handedness (for standardized tDCS targeting)
7. Education level ≥ 6 years
8. Able and willing to undergo all study procedures (neuropsychological testing, MRI, EEG, etc.) and to provide written informed consent
Exclusion Criteria:
1. Contraindications to MRI or EEG (e.g., pacemaker, metallic implants, claustrophobia).
2. Active neurological/psychiatric disorders (e.g., major depressive disorder, bipolar disorder, schizophrenia, Parkinson's disease, post-stroke sequelae)
3. Concurrent use of cognition-enhancing medications (e.g., donepezil, memantine)
4. Severe somatic diseases (cardiac/hepatic/renal insufficiency)
5. Pregnant or breastfeeding
6. Concurrent participation in another interventional clinical trial
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07083518
Study Brief:
Protocol Section:
NCT07083518